Novel 99mTc labeled a receptor ligand as a potential tumor imaging agent

Science in China, Series B: Chemistry

Volumn 49, Issue 2, 2006, Pages 169-176

  Fan, Caiyun ^a   Jia, Hongmei ^a   Winnie, Deuther Conrad ^b   Peter, Brust ^b   Jorg, Steinbach ^b   Liu, Boli ^a  

^a BEIJING NORMAL UNIVERSITY   (China)

^b Institute of Interdisciplinary Isotope Research   (Germany)

Author keywords

receptor; 99mTc; SPECT; Tumor

Indexed keywords

COMPLEXATION; IMAGING TECHNIQUES; LEAD COMPOUNDS; MODIFICATION; RHENIUM COMPOUNDS; TUMORS;

PLANAR IMAGES; POTENTIAL TUMOR IMAGING AGENT; RECEPTOR LIGAND; RHENIUM COMPLEX;

TECHNETIUM COMPOUNDS;

EID: 33745157528     PISSN: 10069291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11426-006-0169-z     Document Type: Article

References (46)

1. Quirion, R., Bowen, W. D., Itzhak, Y. et al., A proposal for the classification of sigma binding sites, Trends Pharmacol. Sci., 1992, 13: 85-86.
2. Su, T. P., Sigma receptors: Putative links between nervous, endocrine and immune systems, Eur. J. Biochem., 1991, 200: 633-642.
3. Guitart, X., Codony, X., Monroy, X., Sigma receptors: Biology and therapeutic potential, Psychopharmacology, 2004, 174: 301-319.
4. Vilner, B. J., John, C. S., Bowen, W. D., Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines, Cancer Res., 1995, 55: 408-413.
5. 2 receptors as potential biomarkers of proliferation in breast cancer, Cancer Res., 1997, 57: 156-161.
6. 18F]fluorobenzamide: A potential ligand for PET imaging of σ receptors, Nucl. Med. Biol., 1997, 24: 671-676.
7. 18F] labeled benzamides: High affinity sigma receptor ligands for PET imaging, Nucl. Med. Biol., 1997, 24: 333-340.
8. 18F]fluorobenzamide: A potential ligand for PET imaging of breast cancer, Nucl. Med. Biol., 2000, 27: 763-767.
9. Rowland, D. J., Tu, Z., Mach, R. H. et al, Investigation of a new sigma-2 receptor ligand for detection of breast cancer, J. Labelled Cpd. Radiopharm., 2003, 46: S6.
10. Everaert, H., Flamen, P., Franken, P. R. et al, Sigma receptor imaging by means of 123-IDAB scintigraphy; clinical application in melanoma and non-small cell lung cancer, Anticancer Res., 1997, 17: 1577-1582.
11. 125I]BP: A potential a receptor marker for human prostate tumors, Nucl. Med. Biol., 1998, 25: 189-194.
12. 123I]-4-iodo-N - (4-(4-(2-me-thoxyphenyl)-piperazin-1-yl)butyl)-benzamide: A potential sigma receptor ligand for SPECT studies, Nucl. Med. Biol., 2005, 32: 193-200.
13. 18F-labeled guanidines, J. Med. Chem., 1991, 34: 1867-1870.
14. 11C]NE-100 labeled in two different positions as a PET σ receptor ligand, Nucl. Med. Biol., 1998, 25: 195-202.
15. 11C]benzyl-N-normetazocine, J. Labelled Cpd. Radiopharm., 1994, 34: 49-57.
16. 18F]-1-(3-fluoropropyl)-4-(4-cyanophenoxymefhyl) piperidine, J. Labelled Cpd. Radiopharm., 1996, 38: 785-794.
17. 18F]1-(3-fluoropropyl)-4-(4-cyanophenoxymethyl) piperidine: A selective sigma-1 receptor radioligand for PET, Nucl. Med. Biol., 1997, 24: 127-134.
18. 125I]N-[2-(4-iodo-phen-yl)ethyl]- N -methyl-2-(1-piperidinyl)ethylamine: A high-affinity ligand for imaging sigma receptor positive tumors, Nucl. Med. Biol., 1996, 23: 761-766.
19. 123I]-1-(iodopropen-2-yl)-4-[(4-cyanophenoxy)methyl] piperidine, J. Med. Chem., 1997, 40: 1657-1667.
20. 123I]1-(4-cyanobenzyl)- 4 -[[(trans-iodopropen-2-yl)oxy]-methyl] piperidine: A novel high affinity sigma receptor radioligand for SPECT, Nucl. Med. Biol., 1997, 24: 45-51.
21. 123I-labeled piperidine-based sigma receptor ligands as potential melanoma imaging agents: Initial studies in mouse tumor models, Nucl. Med. Biol., 1997, 24: 587-593.
22. 125I-4-(N-benzyIpiperidin)-4-iodo-phenylsulfonamide, J. Isotopes (in Chinese), 2004, 17: 198-203.
23. Maier, C. A., Wünsch, B., Novel spiropiperidines as highly potent and subtype selective sigma-receptor ligands, Part 1, J. Med. Chem., 2002, 45: 438-448.
24. Maier, C. A., Wiinsch, B., Novel sigma receptor ligands, Part 2. SAR of spiro[[2]benzopyran-1,4'-piperidines] and spiro[[2]ben-zofuran-1,4'-piperidines] with carbon substituents in position 3, J. Med. Chem., 2002, 45: 4923-4930.
25. Ding, Y. S., Fowler, J. S., Dewey, S. L. et al., Synthesis and PET studies of fluorine-18-BMY 14802: A potential antipsychotic drug, J. Nucl. Med., 1993, 34: 246-254.
26. 4-2-([3,4-dichlorophenyl]ethyl)piperazine, a high affinity ligand for sigma receptor, J. Labelled Cpd. Radiopharm., 1993, 33: 639-643.
27. 11C-SA4503: A feasibility study, J. Nucl. Med., 2004, 45: 1939-1945.
28. 18F]fluoroethyl SA4503 and SA5845 as PET ligand for the sigma receptor, J. Labelled Cpd. Radiopharm., 2001, 44(Suppl.1): S4-S6.
29. 11C-labeled SA4503, SA5845, and their ethyl derivatives as PET sigma receptor ligands, J. Labelled Cpd. Radiopharm., 2001, 44(Suppl.1): S233-S235.
30. 1 receptor ligand, Nucl. Med. Biol., 1999, 26: 915-922.
31. 1 receptor, Nucl. Med. Biol., 2000, 27: 255-261.
32. 18F-labeled 1-[2-(4-alkoxy-3-methoxy-phenyl)ethyl]-4-(3-phenylpropyl)piperazines as sigma receptor ligands for positron emission tomography studies, Nucl. Med. Biol., 2003, 30: 273-284.
33. 99mTc-labeled σ-receptor-binding complex: Synthesis, characterization, and specific binding to human ductal breast carcinoma (T47D) cells, Bioconj. Chem., 1997, 8: 304-309.
34. Choi, S-R., Yang, B. Plossl, K. et al., Development of a Tc-99m labeled sigma-2 receptor-specific ligand as a potential breast tumor imaging agent, Nucl. Med. Biol., 2001, 28: 657-666.
35. Zhang, Y., Williams, W., Torrence-Campbell, C. et al., Characterization of novel N,N'-disubstituted piperazines as sigma receptor ligands, J. Med. Chem., 1998, 41: 4950-4957.
36. Maeda, D. N., Williams, W., Kim, W. E. et al., N-arylalkylpiperidines as high-affinuty sigma-1 and sigma-2 receptor ligands: Phenylpropylamine as potential leads for selective sigma-2 agents, Bioorg. Med. Chem. Lett., 2002, 12: 497-500.
37. Moore, T. S., Boyle, M., Thorn, V. M. et al., N-substituted derivatives of piperazine and ethylenediamine, Part I. The preparation of N-monosubstituted derivatives, J. Chem. Soc., 1929: 39. 38.
38. Stewart, H. W., Turner, R. J., Denton, J. J. et al., Experimental chemotherapy of filariasis, IV. The preparation of derivatives of piperazine, J. Org. Chem., 1948, 13: 134-143.
39. O'Neil, J. P., Wilson, S. R., Katzenellenbogen, J. A., Preparation and structural characterization of monoamine-monoamide bis(thio) oxo complexes of technetium(V) and rhenium(V), Inorg. Chem., 1994, 33: 319-323.
40. Bowen, W. D., Sigma receptors: Recent advances and new clinical potentials, Pharm. Acta Helv., 2000, 74: 211-218.
41. Deuther-Conrad, W., Patt, J. T., Feuerbach, D. et al., Norchloro-fluoro-homoepibatidine: Specificity to neuronal nicotinic acetylcholine receptor subtypes in vitro, IL Farmaco, 2004, 59: 785-792.
42. Vilner, B. J., Bowen, W. D., Modulation of cellular calcium by sigma-2 receptors: Release form intracellular stores in human SK-N-SH neuroblastoma cells, J. Pharmacol. Exp. Ther., 2000, 292: 900-911.
43. 50) of an enzymatic reaction, Biochem. Pharmacol., 1973, 22: 3099-3108.
44. Kung, H. F, Kim, H-J., Kung, M-P. et al., Imaging of dopamine transporters in humans with technetium-99 m TRODAT-1, Eur. J. Nucl. Med., 1996,23: 1527-1530.
45. Callahan, R. J., Dragotakes, S. C., Barrow, S. A. et al, A phase I clinical trial of the DAT ligand 99 mTc-O1505T, J. Med. Chem., 2003, 46: 3483-3496.
46. 2 agonists and sigmai antagonists in tumour cell lines, Naunyn Schmiedebergs Arch. Pharmacol., 2004, 370: 106-113.